AISAP Cardio vs cmAngio®
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your clinical setting requires immediate, AI-powered cardiac diagnostic assessments directly at the point of care. This tool is ideal for rapidly detecting structural heart disease and heart failure, providing comprehensive measurements like Left Ventricle Ejection Fraction (LVEF) and assessing valvular pathologies at the bedside. It streamlines emergency medicine and cardiology workflows by automating analyses and reports for quick decision-making.
View AISAP Cardio →Choose cmAngio® if…
Choose cmAngio® if you aim to leverage existing mammography screenings for early cardiovascular risk assessment in women. This AI software is specifically designed to detect Breast Arterial Calcifications (BAC) on both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams, offering valuable insights into a patient's cardiovascular health without additional procedures or radiation. It seamlessly integrates into radiology and women's health practices to enhance preventative care by identifying potential cardiac risks during routine breast imaging.
View cmAngio® →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | cmAngio® |
|---|---|---|
| Pricing | Unknown | Paid, out-of-pocket |
| Deployment | Cloud-based | Cloud-based, integrates with any DICOM-compliant viewer |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | cmAngio® |
|---|---|---|
| Name | AISAP Cardio | cmAngiou00ae |
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. |
| Company | Aisap | CureMetrix |
| Categories | Cardiology AI | Cardiology AI, OB/GYN AI, Radiology & Imaging AI |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Obstetrics & Gynecology, Radiology |
| Key Features | AI-powered interpretation for early cardiac disease detection, Comprehensive cardiac ultrasound software package, Automated generation of analyses, interpretations, and reports, Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Measurement of Left Ventricle Ejection Fraction (LVEF), Measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter, Vendor-agnostic and scalable solution, Integration with existing clinical workflows, EHR/EMR, and PACS | AI-based detection of Breast Arterial Calcifications (BAC), Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams, Provides visualization of BAC location on a scorecard, Enables BAC identification and reporting without additional radiation or procedures, Compatible with any DICOM-compliant viewer, Adjustable operating point to meet clinical goals, Quick and easy installation (less than an hour), Cybersecure and HIPAA-compliant |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and cmAngio®.